Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Through the partnership J&K Ingredients can provide a more coordinated approach with enhanced supply security, accelerated development and commercialization timeliness, and increased agility in ...

Billionaire investor Jim Mellon has revealed plans to bring large-scale “clean food” manufacturing to the Middle East, positioning the UAE as a future global hub for precision-fermented proteins and ...

Islamic clerics and experts have thrown their weight behind the adoption of genetically modified organisms (GMOs) and biotechnology in agriculture, citing their potential to solve Nigeria’s deepening ...

Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full ...

GSK is paying $2.2 billion to buy Rapt Therapeutics and its anti-immunoglobulin E (IgE) antibody to protect against food allergy reactions. Rapt only licensed the therapy, called ozureprubart, from ...

National Biotechnology Research and Development Agency (NBRDA) has called on Nigerian farmers to embrace biotechnology as a safe, proven, and effective tool for increasing agricultural productivity ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company potential accurately and confidently.